Department of Gastroenterological Surgery I, Hokkaido University Hospital, Sapporo, Japan.
Department of Gastroenterological Surgery I, Hokkaido University Hospital, Sapporo, Japan
Anticancer Res. 2023 Nov;43(11):5245-5252. doi: 10.21873/anticanres.16726.
BACKGROUND/AIM: To evaluate the feasibility of laparoscopic and robotic total proctocolectomy (TPC) for ulcerative colitis-associated colorectal cancer (UC-CRC).
We retrospectively analyzed the postoperative outcomes of TPC in 13 patients with UC-CRC between January 2011 and December 2021. Laparoscopic TPC was performed in 10 patients. TPC consisted of two procedures: ileal pouch-anal anastomosis (IAA) and TPC with end ileostomy. Using the da Vinci Xi platform with six ports, robotic TPC and abdominal perineal resection (APR) were performed in two and one patients, respectively. Transanal total mesorectal excision (TaTME) was performed using the perineal approach in five patients.
UC-CRC was located in the transverse colon, sigmoid colon, rectum, and anal canal in 1, 1, 10, and 1 patients, respectively. IAA, TPC with end ileostomy, and APR were performed in nine, three, and one patients, respectively. Postoperative complications included colitis, portal vein thrombosis, and liver dysfunction, without mortality. The pathological stages were 0, I, IIa, IIIb, and IIIc in five, four, one, two, and one patients, respectively. The tumors were completely resected in all cases. Eleven patients with pStages 0, I, and II survived without recurrence; however, two patients with pStage III died of cancer recurrence.
This study demonstrated the feasibility of laparoscopic and robotic TPC in patients with UC-CRC. However, long-term outcomes in terms of oncology and patient quality of life must be investigated in future large-scale studies.
背景/目的:评估腹腔镜和机器人全直肠结肠切除术(TPC)治疗溃疡性结肠炎相关结直肠癌(UC-CRC)的可行性。
我们回顾性分析了 2011 年 1 月至 2021 年 12 月期间 13 例 UC-CRC 患者的 TPC 术后结果。10 例患者行腹腔镜 TPC。TPC 包括两种手术:回肠储袋肛管吻合术(IAA)和 TPC 加末端回肠造口术。使用达芬奇 Xi 平台的六个端口,对两名和一名患者分别进行机器人 TPC 和腹部会阴切除术(APR)。五名患者采用经肛门全直肠系膜切除术(TaTME)经会阴入路进行。
UC-CRC 分别位于横结肠、乙状结肠、直肠和肛管的 1、1、10 和 1 例患者中。9 例患者行 IAA、3 例患者行 TPC 加末端回肠造口术、1 例患者行 APR。术后并发症包括结肠炎、门静脉血栓形成和肝功能障碍,但无死亡。病理分期为 5 例 0 期、4 例 I 期、1 例 IIa 期、2 例 IIIb 期和 1 例 IIIc 期。所有病例均完全切除肿瘤。11 例 p 分期为 0、I 和 II 的患者无复发存活;然而,2 例 p 分期为 III 的患者死于癌症复发。
本研究表明腹腔镜和机器人 TPC 治疗 UC-CRC 是可行的。然而,未来需要在大规模研究中调查其在肿瘤学和患者生活质量方面的长期结果。